CEOs at big data technology companies sound off on what they see as the opportunities for channel partners in 2026.
Market Guide highlights the market’s shift from ad hoc, IT-centric remote access toward purpose-built CPS secure remote ...
TransMedics TMDX recently announced that it has received full and unconditional FDA Investigational Device Exemption (IDE) approval for its next-generation OCS ENHANCE Heart trial, eliminating a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results